Join Now

Category Archives: BioUtah News

PolarityTE Reports Third Quarter Financial Results and Provides Business Update

By Natalie Themm | Published November 10, 2021

PolarityTE, Inc. recently provided a business update and reported financial results for the three and nine-month periods ended September 30, 2021.

| Tagged | Leave a comment

Renalytix Convenes Expert Panel at VA Healthcare Summit

By Natalie Themm | Published November 10, 2021

Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease

| Tagged | Leave a comment

St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York

By Natalie Themm | Published November 9, 2021

Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease

| Tagged | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma 

By Denise Bell | Published November 4, 2021

Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first patient has been dosed in a Phase 1 study evaluating its investigational agent DSP-0390, an emopamil-binding protein (EBP) inhibitor, for the treatment of patients with recurrent high-grade glioma. “Dosing the first patient in this study represents another […]

Also posted in Industry News, Utah's Life Sciences Companies | | Leave a comment

Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom

By Natalie Themm | Published November 4, 2021

Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations

| Tagged , | Leave a comment

New report shows more than 260 medicines in development to fight neurodegenerative diseases

By Natalie Themm | Published November 3, 2021

PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases

| Tagged | Leave a comment

Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial

By Natalie Themm | Published November 3, 2021

Clene recently announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying treatment for people with early amyotrophic lateral sclerosis (ALS).

| Tagged , | Leave a comment

Wilson Sonsini to open Salt Lake City office with trio of lawyers

By Natalie Themm | Published November 3, 2021

Wilson Sonsini Goodrich & Rosati to open an office in Salt Lake City, becoming the latest major U.S. law firm to plant a flag in the tech-heavy region sometimes called “Silicon Slopes.”

| Tagged | Leave a comment

Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans

By Natalie Themm | Published November 3, 2021

Myriad Genetics announced financial results for its third quarter ended September 30, 2021 and provided an update on recent business performance and strategic transformation plans.  

| Tagged | Leave a comment

FDA Clears 12 New XO Cross Microcatheters

By Natalie Themm | Published November 3, 2021

12 new hydrophilic-coated micro and support catheters cleared by FDA for broad use in the peripheral vasculature.

| Tagged | Leave a comment

St. George could become Utah’s next tech hub

By Natalie Themm | Published November 3, 2021

Utah has now become a VC darling with a maturing ecosystem complete with angels, seed-stage, growth stage, and private equity investors, says Brad Plothow, VP of strategy at St. George aerospace startup Intergalactic.

| Tagged | Leave a comment

Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery

By Natalie Themm | Published November 3, 2021

Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery

| Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members